August 14, 2013: Bizmatics is pleased to announce the release of an e-prescription module for controlled substances (EPCS) through its electronic medical record software, PrognoCIS EMR. One of the very early providers of EPCS, PrognoCIS enables users to seamlessly and securely transmit e-prescriptions to pharmacies for DEA class I, II, III, IV, and V. The feature enforces two-factor authentication for prescription of narcotic drugs to ensure that drugs are not prescribed by unauthorized employees like medical assistants, nurses or administrative staff. PrognoCIS, as well as Surescripts®, keeps track of every prescription for auditing purposes. It then makes those prescriptions available as part of a patient’s medication history, regardless of where and by whom the prescription was given.
“Today thousands of PrognoCIS providers are using e-prescription for non-controlled substance drugs but are forced to print prescriptions for DEA class I, II, III, IV, and V. The new EPCS feature will eliminate the need to print such prescriptions. It will be a great relief for physicians and patients and will also control the possible misuse of printed prescriptions,” said Vinay Deshpande, CEO of Bizmatics.
As suggested, exchanging prescription information electronically between physicians and pharmacies improves the accuracy of the prescribing process and saves time. Time savings primarily result from reduced pharmacy phone calls and faxes related to prescription renewal authorizations, as well as from a reduced need for pharmacy staff to enter prescription data.
According to the HITECH Act, e-prescribing systems are essential to achieving meaningful use. For this reason, the market is constantly growing and new products are emerging everywhere to incorporate e-prescription solutions. Bizmatics goes one step further by allowing electronic prescriptions to be transmitted through devices such as iPads® and smartphones. EPCS will also be available on the PrognoCIS iPhone® app in the next few weeks.